evidencegaps
Primary study · included by 1 review

Health-related quality of life in long-term differentiated thyroid cancer survivors: A cross-sectional Tunisian-based study.

Missaoui 2022 · Missaoui Abdel Mouhaymen, Hamza Fatma, Maaloul Mohamed, et al. · Frontiers in endocrinology · 2022

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Missaoui 2022 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Sialadenitis (pooled prevalence)
Radioiodine (I131) therapy · more than 1 year after RIT
Prevalence 0.24 [0.21, 0.29]3 studies · 405 participantsGRADE not reported

1 including review in total.